NMN vs NR: Which NAD+ Precursor Should You Take?

By Dr Chun Tang — MBChB (Manchester), MRCGP, MBA · Practising NHS & Private GP · Founder, Little Ox

NMN vs NR: An NHS GP's Honest Comparison of the Two Leading NAD+ Precursors

If you've been researching NAD+ supplements, you've almost certainly encountered two names: NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside). Both raise NAD+ levels. Both have clinical trial data. And both have vocal advocates making strong claims.

Here's my honest clinical assessment of what the evidence shows — and which I recommend to my patients and take myself.

The Biochemistry: Where They Fit in the NAD+ Pathway

Both NMN and NR are precursors to NAD+ — meaning the body converts them into NAD+. The key difference is where they enter the conversion pathway.

The pathway looks like this: Tryptophan → Niacin → NR → NMN → NAD+

NMN is one step closer to NAD+ than NR. Once inside the cell, NMN converts directly to NAD+ via the enzyme NMNAT. NR requires an additional enzymatic step — it must first be converted to NMN by nicotinamide riboside kinases (NRK1 and NRK2) before becoming NAD+.

This makes NMN the more direct precursor. But biochemical directness doesn't automatically mean clinical superiority — absorption and bioavailability matter too.

Absorption: The Critical Debate

For years, there was uncertainty about whether NMN could be absorbed directly by cells. Early research suggested it might need to be converted to NR outside the cell first, then reconverted to NMN inside. This would make NMN functionally equivalent to NR in terms of the effective pathway.

However, a landmark 2019 paper in Nature Metabolism identified a specific NMN transporter — Slc12a8 — that allows NMN to enter intestinal cells directly. This transporter is particularly active in the small intestine and is upregulated as mice age. The discovery of this transporter significantly strengthened the case for NMN's direct absorption and bioavailability.

Clinical Evidence: What the Human Trials Show

NMN human trials have shown: measurable increases in blood NAD+, improved muscle insulin sensitivity (the 2021 Science trial in postmenopausal women), improvements in aerobic capacity in older adults, and enhanced muscle function in physically active men.

NR human trials have shown: reliable increases in blood NAD+ levels (consistently demonstrated across multiple trials), benefits in Parkinson's disease models, and some cardiovascular health signals.

Both have meaningful clinical evidence. NMN's recent trial data is arguably more diverse in the outcomes it has measured, but NR has a longer clinical research history (it's been studied in humans since around 2016, slightly ahead of NMN trials).

Tissue Targeting: The Important Distinction

Emerging research suggests that NMN and NR may preferentially raise NAD+ in different tissues. NMN appears to be more effective at raising NAD+ in muscle, heart and brain tissue. NR primarily raises NAD+ in liver tissue and blood cells.

This distinction matters clinically. If your primary goal is metabolic health, energy and muscle function — as is the case for most people taking NAD+ supplements — NMN's tissue targeting is more directly relevant.

Price: The Practical Consideration

NR supplements — particularly branded options like Tru Niagen — typically cost £40–60 per month. NMN has become significantly more affordable as manufacturing has scaled. Our NMN Pure costs £7.99 per month — high-quality, independently tested high-purity β-NMN, independently third-party tested.

When NR and NMN show broadly comparable clinical outcomes, and NMN is available at a fraction of the cost, the value case for NMN is clear.

My Recommendation

I take NMN myself — specifically NMN Plus (NMN with Trans-Resveratrol) every morning. The combination of NMN's direct cellular pathway, the muscle and brain tissue targeting supported by recent research, and the emerging human trial data makes NMN my preferred choice as a clinician.

For patients who have been taking NR and finding it effective, I see no strong reason to switch. But for someone starting NAD+ supplementation for the first time, NMN is what I recommend — and at £7.99/month, the price difference makes the decision easier.

Wondering how Little Ox compares to other UK NMN brands on price and quality? We've put together a full comparison of Little Ox vs Charava, DoNotAge and Longevity Formulas — including current prices, purity specs and what you're actually paying for.

Related reading:

All Little Ox NMN products are independently third-party tested on every batch. You can view our Certificates of Analysis and manufacturing certifications — including GMP (Intertek), ISO 22000, HACCP and FDA registration — on our quality assurance page.

Shop NMN Pure — from £7.99 → Shop NMN Plus — from £9.99 →

Written under the clinical oversight of Dr Chun Tang, MBChB, MRCGP — founder of Little Ox and practising UK GP with 26 years of clinical experience. This article is for informational purposes and does not constitute medical advice.